Charles River Laboratories International Inc
NYSE:CRL
Charles River Laboratories International Inc
NYSE:CRL
Price:
214.51 USD
-1.24%
Market Closed
Updated:
May 29, 2024
Charles River Laboratories International Inc
Total Equity
|
Charles River Laboratories International Inc
Total Equity Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Charles River Laboratories International Inc
NYSE:CRL
|
Total Equity
$3.6B
|
CAGR 3-Years
19%
|
CAGR 5-Years
21%
|
CAGR 10-Years
18%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Total Equity
$45.5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
10%
|
CAGR 10-Years
8%
|
|
|
Danaher Corp
NYSE:DHR
|
Total Equity
$53.4B
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
9%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Total Equity
-$158.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Agilent Technologies Inc
NYSE:A
|
Total Equity
$6.2B
|
CAGR 3-Years
9%
|
CAGR 5-Years
4%
|
CAGR 10-Years
1%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Total Equity
$6.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
See Also
What is Charles River Laboratories International Inc's Total Equity?
Total Equity
3.6B
USD
3.6B
USD
Based on the financial report for Mar 30, 2024, Charles River Laboratories International Inc's Total Equity amounts to 3.6B USD.
What is Charles River Laboratories International Inc's Total Equity growth rate?
Total Equity CAGR 10Y
18%
18%
Over the last year, the Total Equity growth was 17%. The average annual Total Equity growth rates for Charles River Laboratories International Inc have been 19% over the past three years , 21% over the past five years , and 18% over the past ten years .
You don't have any saved screeners yet
